• News & Events
  • [Jan. 11] D5 Seminar-Dr. Masayuki Yazawa (Columbia University Irving Medical Center)
What's new

News & Events

[Jan. 11] D5 Seminar-Dr. Masayuki Yazawa (Columbia University Irving Medical Center)

December 26 2022

The "D5 Medical & Life Science Seminar" course will be offered by International Research Center for Medical Sciences (IRCMS). It will run from May 2022 to March 2023, with lectures given by scientists who are affiliated with IRCMS or in collaboration with researchers at IRCMS. The lectures will be given once a month, in English, and by leading scientists in the relevant research field. Students will be taught: 1) how normal physiological functions are maintained in the human body; 2) how these systems become abnormal under certain pathophysiologic conditions; 3) why stem cells are important in animal development and homeostasis; 4) how stem cell-based approaches can help us understand disease mechanisms and find potential cure for diseases related to stem cell malfunction (e.g., cancer, aging).

Anyone who wants to join is welcome.
For students who have registered for the course, please check your attendance in Moodle.

Date      : January 11, 2022 (Wednesday)

Venue: Onsite & Online
            IRCMS Lounge, IRCMS Building & Zoom

Time      : 16:00 -

Speaker : Dr. Masayuki Yazawa
                Columbia University

Title        :  Targeting Ion Channels for Drug Discovery - Cardiac arrhythmia & COVID-19

Abstract :
Various biotechnologies such as human iPS (induced pluripotent stem) cell, electrophysiology, fluorescent imaging, molecular biology and omics have allowed scientists to address their biological questions and conduct translational research to improve human health. A variety of outcomes from basic science including physiology, genetics and organ development have resulted in development of new technologies and improvement of experimental approaches and also facilitated biomedical research. At this seminar, I will talk about our new experimental approaches that enable us for unveiling the molecular mechanisms underlying pathophysiological conditions in emergent diseases such as genetic lethal cardiac arrhythmia and COVID-19 to identify new therapeutics.

Flyer: (Click to enlarge)